Levmetamfetamine

DB09571ApprovedSmall molecule

Levomethamphetamine, the L-enantiomer of methamphetamine is a sympathomimetic vasoconstrictor used in some over-the-counter (OTC) nasal decongestant inhalers in the United States.

Mechanism: Levomethamphetamine crosses the blood-brain-barrier and acts as a TAAR1 agonist, functioning as a selective norepinephrine releasing agent in the central nervous system,
Curator reviewed
Primary indication: Used over-the-counter for nasal congestion.Curator reviewed · 1 structured indication
Formula / weight: C₁₀H₁₅N · 149.237 g/mol (avg)
Also known as: Levomethamphetamine

Resolves to

Compound

UNIIY24T9BT2Q2CAS33817-09-3ChEMBLCHEMBL1927030ChEBI136013PubChem36604

Clinical / RWD

RxNorm1314416

Structure

InChIKeyMYWUZJCMWCOHBA-SECBINFHSA-NSMILESCN[C@H](C)CC1=CC=CC=C1

What you can answer from here — as of September 28, 2021

1Clinical trialPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

15Marketed productsAcross 1 country and 14 labellers

3+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Levmetamfetamine, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account